New Tools for Science Policy

Public Funding, Patents, and Technology Transfer: Learning from the Contrasting Oxford and Texas Models of COVID-19 Vaccine Production and Distribution Recording

About the Seminar

April 29, 2024 9:00am—10:00am

The COVID-19 pandemic spurred substantial debate over how to rapidly develop new vaccines, produce billions of doses, and distribute them globally. Central to these debates are the roles of intellectual property, technology transfer, and public funding. Ken Shadlen explored these issues, drawing on the global production experiences of two publicly-funded vaccines developed in university labs: one from the University of Oxford in the UK, and the other from Baylor College of Medicine in the US. The presentation examined how the innovation ecosystem functioned during the COVID-19 pandemic and offered insights for policymakers preparing for future pandemics and other global challenges.